On Monday, GT Biopharma Inc (NASDAQ: GTBP) was 6.56% up from the session before settling in for the closing price of $0.61. A 52-week range for GTBP has been $0.54 – $4.10.
Annual sales at Healthcare sector company grew by 54.16% over the past five years. When this article was written, the company’s average yearly earnings per share was at 76.08%. With a float of $9.26 million, this company’s outstanding shares have now reached $10.64 million.
GT Biopharma Inc (GTBP) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward GT Biopharma Inc stocks. The insider ownership of GT Biopharma Inc is 12.92%, while institutional ownership is 4.93%.
GT Biopharma Inc (GTBP) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -1.66 earnings per share (EPS) during the time that was less than consensus figure (set at -1.55) by -0.11.
According to the Wall Street analysts, stocks earnings will be around 76.08% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 56.28% during the next five years compared to 54.16% growth over the previous five years of trading.
GT Biopharma Inc (NASDAQ: GTBP) Trading Performance Indicators
You can see what GT Biopharma Inc (GTBP) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.39, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.70 in one year’s time.
Technical Analysis of GT Biopharma Inc (GTBP)
GT Biopharma Inc (NASDAQ: GTBP) saw its 5-day average volume 1.25 million, a positive change from its year-to-date volume of 0.76 million. As of the previous 9 days, the stock’s Stochastic %D was 19.70%.
During the past 100 days, GT Biopharma Inc’s (GTBP) raw stochastic average was set at 6.25%, which indicates a significant decrease from 27.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0694 in the past 14 days, which was lower than the 0.1067 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6937, while its 200-day Moving Average is $1.7552. Nevertheless, the first resistance level for the watch stands at $0.6668 in the near term. At $0.6842, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.7126. If the price goes on to break the first support level at $0.6210, it is likely to go to the next support level at $0.5926. The third support level lies at $0.5752 if the price breaches the second support level.
GT Biopharma Inc (NASDAQ: GTBP) Key Stats
There are 10,636K outstanding shares of the company, which has a market capitalization of 6.91 million. As of now, sales total 0 K while income totals -13,160 K. Its latest quarter income was 0 K while its last quarter net income were -3,110 K.
